Filing metadata

Accession number
0001104659-23-063324
Form type
Form 4
Filer
RVL Pharmaceuticals plc
CIK
CIK 1739426
Filed
May 22, 2023
Reporting period
May 18, 2023
Description
Insider transaction

Explore SEC Filings Hub